Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Randomized Trial of CHOP With or Without Bortezomib in Relapsed Mantle Cell Lymphoma
2006-006090-24Phase 2Completed
- Sponsor
- University Hospitals Plymouth
- Start
- Jan 2007
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bortezomib in mantle cell lymphoma (MCL) (2 arms), sponsored by University Hospitals Plymouth. Primary endpoints: Disease progression, Overall response rate and 1 more. Started Jan 2007; status: completed.
02
Drugs
bortezomib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on 2006-006090-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006090-24.